FOLFIRI regimen: an effective second-line chemotherapy after failure of etoposide-platinum combination in patients with neuroendocrine carcinomas grade 3.
暂无分享，去创建一个
P. Ruszniewski | A. Couvelard | V. Rebours | P. Lévy | O. Hentic | F. Maire | P. Hammel | M. Zappa | M. Palazzo | G. Goujon | A. Gillet | P. Lévy | Adeline Gillet